Caribou Biosciences (CRBU) Return on Capital Employed Growth (3y) (2024 - 2026)
Caribou Biosciences (CRBU) Return on Capital Employed Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,132.22 Bn | 67,131.94 Bn | - | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 973.81 Bn | 973.81 Bn | - | - |
| 4 | BeOne Medicines | 471.45 Bn | 466.66 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 122.00 Bn | 114.75 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 69.99 Bn | 61.23 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.86 Bn | 50.67 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | 4,853.00 |
| 10 | Caribou Biosciences | 154.82 Mn | 37.19 Mn | - | -5,744.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,744.00 |
| Dec 31, 2025 | -6,315.00 |
| Sep 30, 2025 | -6,302.00 |
| Jun 30, 2025 | -5,493.00 |
| Mar 31, 2025 | -4,355.00 |
| Dec 31, 2024 | -3,989.00 |
| Sep 30, 2024 | -2,843.00 |